• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2023年世界心脏联盟新标准在首次急性风湿热发作背景下对风湿性心脏病的应用:缓解的预测因素

Application of the New 2023 World Heart Federation Criteria to Rheumatic Heart Disease in the Setting of First Episode of Acute Rheumatic Fever: Predictors for Resolution.

作者信息

Williamson Jacqueline M, Whalley Gillian A, Marangou James, Morris Peter S, Wang Zhiqiang, Francis Joshua R, Remenyi Bo

机构信息

Menzies School of Health Research, 105 Rocklands Dr, Tiwi, NT, 0810, Australia.

Charles Darwin University, Casuarina, NT, Australia.

出版信息

Pediatr Cardiol. 2025 Sep 3. doi: 10.1007/s00246-025-03966-7.

DOI:10.1007/s00246-025-03966-7
PMID:40900193
Abstract

Rheumatic heart disease (RHD) is a chronic complication of acute rhematic fever (ARF). Echocardiography is used to assess valve disease in ARF. Acute valvulitis in ARF may normalise once inflammation has subsided. In the Top End of the Northern Territory (NT), a diagnosis of RHD is regularly made in conjunction with ARF diagnosis. We aimed to determine if baseline echocardiogram features could predict resolution of RHD when diagnosed during ARF. This retrospective cohort study includes children and young Australians diagnosed concurrently with first ARF and RHD between January 2012 and December 2021. Echocardiograms were reclassified based on the 2023 World Heart Federation guidelines for diagnosis of RHD. Primary outcome was echocardiographic resolution of RHD. The NT register recorded 311 individuals with concurrent diagnoses of ARF and RHD with 165 eligible for inclusion. Median age was 10 years (IQR 8-13 years), and 51.5% were female. Early RHD was diagnosed in 64% (106/165) of cases. Median follow-up time was 34 months. Resolution of RHD occurred in 19% (32/165) and 97% (31/32) of those had Early RHD at diagnosis. Absence of mitral valve leaflet thickening, restriction, and excessive leaflet motion were all associated with RHD resolution with univariate analysis. Multivariate Cox proportional modelling found that Early RHD at baseline independently predicted RHD resolution with HR of 16.6 (95% CI 2.25-122.74, p = 0.006). No difference was found between Stage A or Stage B RHD, (p = 0.461). The morphological features of valve disease were not as important as the severity in predicting resolution of RHD.

摘要

风湿性心脏病(RHD)是急性风湿热(ARF)的一种慢性并发症。超声心动图用于评估ARF中的瓣膜疾病。ARF中的急性瓣膜炎在炎症消退后可能恢复正常。在北领地(NT)的顶端地区,RHD的诊断通常与ARF的诊断同时进行。我们旨在确定基线超声心动图特征是否能够预测在ARF期间诊断出的RHD的恢复情况。这项回顾性队列研究纳入了2012年1月至2021年12月期间同时被诊断为首次ARF和RHD的澳大利亚儿童和年轻人。根据2023年世界心脏联合会RHD诊断指南对超声心动图进行重新分类。主要结局是RHD的超声心动图恢复情况。NT登记册记录了311例同时诊断为ARF和RHD的个体,其中165例符合纳入标准。中位年龄为10岁(四分位间距8 - 13岁),51.5%为女性。64%(106/165)的病例被诊断为早期RHD。中位随访时间为34个月。19%(32/165)的RHD得到恢复,其中97%(31/32)在诊断时为早期RHD。单因素分析显示,二尖瓣叶增厚、受限和瓣叶运动过度的缺失均与RHD的恢复相关。多变量Cox比例模型发现,基线时的早期RHD独立预测RHD的恢复,风险比为16.6(95%置信区间2.25 - 122.74,p = 0.006)。A期或B期RHD之间未发现差异(p = 0.461)。在预测RHD的恢复方面,瓣膜疾病的形态特征不如严重程度重要。

相似文献

1
Application of the New 2023 World Heart Federation Criteria to Rheumatic Heart Disease in the Setting of First Episode of Acute Rheumatic Fever: Predictors for Resolution.2023年世界心脏联盟新标准在首次急性风湿热发作背景下对风湿性心脏病的应用:缓解的预测因素
Pediatr Cardiol. 2025 Sep 3. doi: 10.1007/s00246-025-03966-7.
2
The Impact of Acute Rheumatic Fever Diagnosis on Rheumatic Heart Disease Severity.急性风湿热诊断对风湿性心脏病严重程度的影响。
Glob Heart. 2025 Aug 29;20(1):72. doi: 10.5334/gh.1454. eCollection 2025.
3
Long-term antibiotic prophylaxis for prevention of rheumatic fever recurrence and progression to rheumatic heart disease.长期抗生素预防治疗风湿热复发和进展为风湿性心脏病。
Cochrane Database Syst Rev. 2024 Sep 23;9(9):CD015779. doi: 10.1002/14651858.CD015779.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Clinical profile of paediatric acute rheumatic fever and rheumatic heart disease in Western Australia: 1987 to 2020.西澳大利亚州儿科急性风湿热和风湿性心脏病的临床特征:1987 年至 2020 年。
J Paediatr Child Health. 2024 Aug;60(8):375-383. doi: 10.1111/jpc.16617. Epub 2024 Jul 25.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: A systematic review.社会决定因素在 A 组链球菌感染、急性风湿热和风湿性心脏病风险和预防中的作用:系统评价。
PLoS Negl Trop Dis. 2018 Jun 13;12(6):e0006577. doi: 10.1371/journal.pntd.0006577. eCollection 2018 Jun.
8
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
9
Systemic and topical antibiotics for chronic rhinosinusitis.用于慢性鼻-鼻窦炎的全身及局部用抗生素
Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011994. doi: 10.1002/14651858.CD011994.pub2.
10
Topical antiseptics for chronic suppurative otitis media.用于慢性化脓性中耳炎的局部用抗菌剂。
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013055. doi: 10.1002/14651858.CD013055.pub3.

本文引用的文献

1
Persistent Valvular Regurgitation After Acute Rheumatic Fever: Early Predictors of Long Term Outcomes in a Pediatric Retrospective Cohort.急性风湿热后持续性瓣膜反流:儿科回顾性队列中长期结局的早期预测因素
Pediatr Cardiol. 2025 Jun;46(5):1289-1295. doi: 10.1007/s00246-024-03547-0. Epub 2024 Jun 19.
2
Outcome following acute and recurrent rheumatic fever.急性和复发性风湿热的结局。
Paediatr Int Child Health. 2024 May;44(1):13-17. doi: 10.1080/20469047.2024.2313330. Epub 2024 Feb 16.
3
Manifestations of Rheumatic Carditis, Regression of Valvular Regurgitation, and Independent Predictors of Mitral Regurgitation Improvement After Rheumatic Carditis in Thai Children.
风湿性心脏炎的表现、瓣膜反流的消退,以及泰国儿童风湿性心脏炎后二尖瓣反流改善的独立预测因素。
Glob Heart. 2024 Feb 7;19(1):16. doi: 10.5334/gh.1295. eCollection 2024.
4
Silent Acute Rheumatic Fever Unmasked by Using Handheld Echocardiography for Febrile Children Presenting in a Rheumatic Heart Disease-Endemic Area.手持式超声心动图在风湿性心脏病流行地区用于发热儿童,揭示出隐匿性急性风湿热。
J Pediatr. 2024 May;268:113954. doi: 10.1016/j.jpeds.2024.113954. Epub 2024 Feb 8.
5
Using Artificial Intelligence for Rheumatic Heart Disease Detection by Echocardiography: Focus on Mitral Regurgitation.利用人工智能通过超声心动图进行风湿性心脏病检测:重点关注二尖瓣反流。
J Am Heart Assoc. 2024 Jan 16;13(2):e031257. doi: 10.1161/JAHA.123.031257.
6
2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease.2023 年世界心脏联盟风湿性心脏病超声心动图诊断指南。
Nat Rev Cardiol. 2024 Apr;21(4):250-263. doi: 10.1038/s41569-023-00940-9. Epub 2023 Nov 2.
7
Recommendations for the Use of Echocardiography in the Evaluation of Rheumatic Heart Disease: A Report from the American Society of Echocardiography.超声心动图在风湿性心脏病评估中的应用建议:美国超声心动图学会报告
J Am Soc Echocardiogr. 2023 Jan;36(1):3-28. doi: 10.1016/j.echo.2022.10.009. Epub 2022 Nov 23.
8
Artificial intelligence for the echocardiographic assessment of valvular heart disease.人工智能在心脏瓣膜病超声心动图评估中的应用。
Heart. 2022 Sep 26;108(20):1592-1599. doi: 10.1136/heartjnl-2021-319725.
9
Rheumatic Heart Valve Disease Pathophysiology and Underlying Mechanisms.风湿性心脏瓣膜病的病理生理学及潜在机制
Front Cardiovasc Med. 2021 Jan 18;7:612716. doi: 10.3389/fcvm.2020.612716. eCollection 2020.
10
The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease.2020 年澳大利亚急性风湿热和风湿性心脏病预防、诊断和管理指南。
Med J Aust. 2021 Mar;214(5):220-227. doi: 10.5694/mja2.50851. Epub 2020 Nov 15.